Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$78.74

-1.23 (-1.54%)

06:34
07/17/17
07/17
06:34
07/17/17
06:34

Alnylam price target raised to $90 from $80 at Ladenburg

Ladenburg Thalmann analyst Christopher James raised his price target for Alnylam Pharmaceuticals to $90 ahead of the upcoming Phase 3 APOLLO readout with patisiran. The analyst says his new target reflects increased confidence in a positive readout. He upped his probability of success for patisiran to 80% from 70% and keeps a Buy rating on Alnylam.

ALNY Alnylam
$78.74

-1.23 (-1.54%)

05/17/17
LTCO
05/17/17
NO CHANGE
Target $80
LTCO
Buy
Alnylam price target raised to $80 from $75 at Ladenburg
Ladenburg Thalmann analyst Christopher James raised his price target for Alnylam (ALNY) to $80 saying the NEURO-TTR data reported by Ionis Pharmaceuticals (IONS) are "quite positive" for patisiran and the upcoming APOLLO readout. The analyst reiterates a Buy rating on Alnylam shares.
05/24/17
PIPR
05/24/17
NO CHANGE
Target $116
PIPR
Overweight
Alnylam share offering a 'smart' move after rally, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff views Alnylam Pharmaceuticals' 5M share offering as "smart" following the recent share rally and ahead of Phase III data on patisiran in September. The analyst looks for the company to launch multiple orphan drugs including patisiran in 2018, fitusiran in hemophilia in 2019 and givosiran in porphyria in 2020. He lowered his price target for the shares to $116 from $118 and reiterates an Overweight rating on Alnylam.
06/26/17
JPMS
06/26/17
NO CHANGE
JPMS
Neutral
Alnylam data support 'compelling emerging clinical profile,' says JPMorgan
JPMorgan analyst Anupam Rama believes this morning's updated Phase 1 data further support the "compelling emerging clinical profile" of Alnylam's givosiran. The analyst, however, keeps a Neutral rating on the shares citing valuation. Rama continues to believe Alnylam shares are "priced for perfection."
06/27/17
FBCO
06/27/17
NO CHANGE
FBCO
Outperform
Alnylam price target raised to $96 from $90 at Credit Suisse
Credit Suisse analyst Alethia Young increased her probability of success for Alnylam's (ALNY) givosian in porphyria to 60% from 40% and keeps an estimate of unadjusted peak sales of $475M, while also noting that the fact that Sanofi (SNY) did not opt into the porphyria program, meaning Alnylam receives full economics. Given the higher chances ascribed to success, Young raised her price target on Alnylam to $96 from $90 and keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

PRTA

Prothena

$60.32

-0.43 (-0.71%)

07:33
10/17/17
10/17
07:33
10/17/17
07:33
Conference/Events
Prothena management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 06

    Nov

HK

Halcon Resources

$5.90

-0.1 (-1.67%)

07:33
10/17/17
10/17
07:33
10/17/17
07:33
Upgrade
Halcon Resources rating change  »

Halcon Resources upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 15

    May

  • 16

    May

ARMK

Aramark

07:33
10/17/17
10/17
07:33
10/17/17
07:33
Recommendations
Aramark analyst commentary  »

Aramark price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

MDXG

MiMedx

$13.51

0.31 (2.35%)

07:32
10/17/17
10/17
07:32
10/17/17
07:32
Hot Stocks
MiMedx notified by FDA to proceed with Phase 2B IND trial for osteoarthritis »

MiMedx has been notified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 08

    Nov

  • 09

    Nov

  • 10

    Nov

  • 13

    Nov

  • 14

    Nov

IPXL

Impax

$19.95

-0.85 (-4.09%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Impax »

Impax, Amneal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

JBL

Jabil Circuit

$28.61

0.37 (1.31%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Recommendations
Jabil Circuit analyst commentary  »

Jabil Circuit strength in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVTCY

Evotec

$51.15

2.3099 (4.73%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Conference/Events
Evotec management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GPRO

GoPro

$9.08

-0.48 (-5.02%)

, CREE

Cree

$29.28

-0.08 (-0.27%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GPRO

GoPro

$9.08

-0.48 (-5.02%)

CREE

Cree

$29.28

-0.08 (-0.27%)

MT

ArcelorMittal

$28.99

-0.36 (-1.23%)

PXD

Pioneer Natural

$143.69

-0.23 (-0.16%)

BABY

Natus Medical

$39.35

-0.75 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

  • 01

    Nov

  • 02

    Nov

CARB

Carbonite

$22.30

-0.5 (-2.19%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Initiation
Carbonite initiated  »

Carbonite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

NEWS

NewStar Financial

$12.13

0.23 (1.93%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Hot Stocks
Breaking Hot Stocks news story on NewStar Financial »

NewStar Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JRVR

James River Group

$41.95

-0.08 (-0.19%)

07:27
10/17/17
10/17
07:27
10/17/17
07:27
Initiation
James River Group initiated  »

James River Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

MDB

MongoDB

07:27
10/17/17
10/17
07:27
10/17/17
07:27
Syndicate
MongoDB IPO deal range increased to $20.00-$22.00 »

MongoDB 's 8M share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

NFLX

Netflix

$202.68

3.19 (1.60%)

07:26
10/17/17
10/17
07:26
10/17/17
07:26
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PSX

Phillips 66

$90.87

-3.56 (-3.77%)

07:26
10/17/17
10/17
07:26
10/17/17
07:26
Recommendations
Phillips 66 analyst commentary  »

Phillips 66 price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

VZ

Verizon

$48.09

0.23 (0.48%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Periodicals
Verizon FiOS stops carrying Univision, WSJ reports »

Verizon FiOS has stopped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

VLO

Valero

$77.42

-0.66 (-0.85%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Recommendations
Valero analyst commentary  »

Valero price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SNDX

Syndax

$12.76

0.39 (3.15%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Syndicate
Syndax raises $25M in a registered direct offering »

Syndax announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMDZ

Immune Design

$10.10

-0.85 (-7.76%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Immune Design to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 08

    Nov

CVS

CVS Health

$72.44

-0.16 (-0.22%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Economic Club of New York to hold a breakfast meeting »

Larry Merlo, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 06

    Nov

  • 12

    Dec

CVS

CVS Health

$72.44

-0.16 (-0.22%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Economic Club of New York to hold a breakfast meeting »

Larry Merlo, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 06

    Nov

  • 12

    Dec

IPXL

Impax

$19.95

-0.85 (-4.09%)

07:24
10/17/17
10/17
07:24
10/17/17
07:24
Hot Stocks
Breaking Hot Stocks news story on Impax »

Impax trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

ANDV

Andeavor

$103.82

-1.55 (-1.47%)

07:24
10/17/17
10/17
07:24
10/17/17
07:24
Recommendations
Andeavor analyst commentary  »

Andeavor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$30.87

-1.05 (-3.29%)

07:23
10/17/17
10/17
07:23
10/17/17
07:23
Initiation
Tactile Systems initiated  »

Tactile Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

AGN

Allergan

07:22
10/17/17
10/17
07:22
10/17/17
07:22
Recommendations
Allergan analyst commentary  »

Allergan court ruling on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

GRPN

Groupon

$4.70

0.07 (1.51%)

07:22
10/17/17
10/17
07:22
10/17/17
07:22
Initiation
Groupon initiated  »

Groupon initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 16

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.